That is the idea behind the Structured Light Observation and Perception Evaluation (SLOPE) Device, the technology our CEVR spinoff, Entoptica, pitched to investors at the PolyU Innovation Investment Roadshow (PIIRS) in Wuhan, at the invitation of the Knowledge Transfer and Entrepreneurship Office (KTEO), PolyU.
Dr Mukhit Kulmaganbetov, Senior Research Fellow at CEVR and CEO and co-founder of Entoptica, introduced the SLOPE Device to investors and the audience. SLOPE is designed to detect functional changes in the early stages of age-related macular degeneration (AMD).
Core technical advantages

Early eye disease detection

Ocular screening

Quick eye test
By combining quantum optics techniques with vision science, SLOPE makes entoptic phenomena much more visible, acting as a highly sensitive probe for macular disease. It also analyses the retina’s response directly, so results do not depend on what the patient reports seeing, making them more objective and reliable.
Application and target audience

Optometrists

Ophthalmologists

Healthcare sectors
Entoptica is now looking for investors and collaborators who share our passion for protecting vision, and we would love to hear from you.
To explore investment or collaboration, please connect with Dr. Mukhit Kulmaganbetov at mukhit.k@cevr.hk or Mr. Benny Tam, business development manager at CEVR, at
bdm@cevr.hk